Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified. more
| Time Frame | IBBQ | S&P500 |
|---|---|---|
| 1-Week Return | 5.66% | -1.8% |
| 1-Month Return | 9.62% | -2.36% |
| 3-Month Return | 13.4% | 13.25% |
| 6-Month Return | 11.49% | 6.13% |
| 1-Year Return | 52.09% | 19.43% |
| 3-Year Return | 57.52% | 69.3% |
| 5-Year Return | 24.99% | 70.86% |
| 10-Year Return | 25.99% | 268.07% |
| Time Frame | IBBQ | S&P500 |
|---|---|---|
| 1-Week Return | 1,665.09% | -61.21% |
| 1-Month Return | 205.72% | -25.22% |
| 3-Month Return | 66.53% | 65.64% |
| 6-Month Return | 24.68% | 12.82% |
| 1-Year Return | 52.09% | 19.43% |
| 3-Year Return | 16.35% | 19.18% |
| 5-Year Return | 4.56% | 11.31% |
| 10-Year Return | 2.34% | 13.92% |
| Stock name | Ticker | Weight |
|---|---|---|
Vertex Pharmaceuticals Inc | VRTX | 8.1% |
Amgen Inc | AMGN | 7.96% |
Gilead Sciences Inc | GILD | 7.1% |
Regeneron Pharmaceuticals Inc | REGN | 4.67% |
Alnylam Pharmaceuticals Inc | ALNY | 2.86% |
Revolution Medicines Inc | RVMDW | 2.63% |
Biogen Inc | BIIB | 2.14% |
Illumina Inc | ILMN | 1.93% |
Roivant Sciences Ltd | ROIV | 1.78% |
Royalty Pharma PLC | RPRX | 1.75% |
Moderna Inc | MRNA | 1.74% |
Argenx SE | ARGX | 1.71% |
United Therapeutics Corp | UTHR | 1.7% |
Insmed Inc | INSM | 1.63% |
Incyte Corp | INCY | 1.58% |
Viatris Inc | VTRS | 1.35% |
Guardant Health Inc | GH | 1.32% |
Neurocrine Biosciences Inc | NBIX | 1.22% |
Medpace Holdings Inc | MEDP | 1.07% |
Ascendis Pharma A/S | Ascendis.Pharma.A.S | 1.07% |
Jazz Pharmaceuticals PLC | Jazz.Pharmaceuticals.PLC | 1.05% |
Bridgebio Pharma Inc | BBIO | 0.99% |
Exelixis Inc | EXEL | 0.97% |
Ionis Pharmaceuticals Inc | IONS | 0.92% |
Axsome Therapeutics Inc | AXSM | 0.89% |
Madrigal Pharmaceuticals Inc | MDGL | 0.86% |
Arrowhead Pharmaceuticals Inc | ARWR | 0.82% |
BioMarin Pharmaceutical Inc | BMRN | 0.81% |
Summit Therapeutics Inc | SMMT | 0.8% |
Cytokinetics Inc | Cytokinetics.Inc | 0.8% |
BioNTech SE | BNTX | 0.76% |
Krystal Biotech Inc | KRYS | 0.74% |
Sanofi SA | SNY | 0.7% |
BeOne Medicines Ltd | BGNE | 0.67% |
Nuvalent Inc | NUVL | 0.66% |
Tempus AI Inc | Tempus.AI.Inc | 0.66% |
Praxis Precision Medicines Inc | Praxis.Precision.Medicines.Inc | 0.63% |
Halozyme Therapeutics Inc | HALO | 0.61% |
Alkermes PLC | ALKS | 0.61% |
Apogee Therapeutics Inc | Apogee.Therapeutics.Inc | 0.6% |
Kymera Therapeutics Inc | KYMR | 0.6% |
ImmunityBio Inc | IBRX | 0.59% |
Protagonist Therapeutics Inc | PTGX | 0.57% |
Immunovant Inc | IMVT | 0.57% |
Vaxcyte Inc | PCVX | 0.57% |
Spyre Therapeutics Inc | SYRE | 0.54% |
Rhythm Pharmaceuticals Inc | RYTM | 0.54% |
Mirum Pharmaceuticals Inc | MIRM | 0.51% |
PTC Therapeutics Inc | PTCT | 0.51% |
Cogent Biosciences Inc | COGT | 0.47% |
Scholar Rock Holding Corp | SRRK | 0.46% |
CG oncology Inc | CG.oncology.Inc | 0.44% |
Invesco Government & Agency Portfolio | Invesco.Government...Agency.Portfolio | 0.43% |
Ligand Pharmaceuticals Inc | LGND | 0.42% |
Twist Bioscience Corp | TWST | 0.41% |
Amneal Pharmaceuticals Inc | AMRX | 0.4% |
Xenon Pharmaceuticals Inc | XENE | 0.39% |
Travere Therapeutics Inc | TVTX | 0.39% |
Abivax SA | ABVX | 0.39% |
CRISPR Therapeutics AG | CRSP | 0.38% |
Caris Life Sciences Inc | CAI | 0.37% |
Indivior Pharmaceuticals Inc | INDV | 0.37% |
Oruka Therapeutics Inc | ORKA | 0.36% |
Centessa Pharmaceuticals PLC | CNTA | 0.35% |
Erasca Inc | ERAS | 0.34% |
Definium Therapeutics Inc | DFTX | 0.33% |
Edgewise Therapeutics Inc | EWTX | 0.33% |
Veracyte Inc | VCYT | 0.33% |
Tango Therapeutics Inc | TNGX | 0.31% |
10X Genomics Inc | TXG | 0.29% |
ACADIA Pharmaceuticals Inc | ACAD | 0.29% |
Denali Therapeutics Inc | DNLI | 0.29% |
Relay Therapeutics Inc | RLAY | 0.28% |
Crinetics Pharmaceuticals Inc | CRNX | 0.28% |
Newamsterdam Pharma Co NV | Newamsterdam.Pharma.Co.NV | 0.28% |
Structure Therapeutics Inc | GPCR | 0.27% |
Beam Therapeutics Inc | BEAM | 0.25% |
Arcutis Biotherapeutics Inc | ARQT | 0.25% |
Dyne Therapeutics Inc | DYN | 0.24% |
Ideaya Biosciences Inc | IDYA | 0.23% |
Adaptive Biotechnologies Corp | ADPT | 0.23% |
uniQure NV | uniQure.NV | 0.22% |
Alumis Inc | Alumis.Inc | 0.22% |
Enliven Therapeutics Inc | ELVN | 0.21% |
Tarsus Pharmaceuticals Inc | TARS | 0.21% |
Ultragenyx Pharmaceutical Inc | RARE | 0.21% |
Vera Therapeutics Inc | VERA | 0.21% |
GRAIL Inc | GRAIL.Inc | 0.2% |
Kiniksa Pharmaceuticals International Plc | Kiniksa.Pharmaceuticals.International.Plc | 0.2% |
Disc Medicine Inc | IRON | 0.2% |
Supernus Pharmaceuticals Inc | SUPN | 0.19% |
BioCryst Pharmaceuticals Inc | BCRX | 0.18% |
Trevi Therapeutics Inc | TRVI | 0.18% |
Legend Biotech Corp | LEGN | 0.18% |
Aurinia Pharmaceuticals Inc | ASCCY | 0.17% |
Pharvaris NV | Pharvaris.NV | 0.17% |
MBX Biosciences Inc | MBX | 0.17% |
Kodiak Sciences Inc | KOD | 0.16% |
Intellia Therapeutics Inc | NTLA | 0.16% |
Ocular Therapeutix Inc | OCUL | 0.16% |
Agios Pharmaceuticals Inc | AGIO | 0.16% |
Vericel Corp | VCEL | 0.15% |
Mineralys Therapeutics Inc | MLYS | 0.15% |
ADMA Biologics Inc | ADMA | 0.15% |
Nurix Therapeutics Inc | NRIX | 0.15% |
Harmony Biosciences Holdings Inc | HRMY | 0.15% |
Taysha Gene Therapies Inc | TSHA | 0.15% |
Genmab A/S | GMAB | 0.14% |
Precigen Inc | PGEN | 0.14% |
Rapport Therapeutics Inc | RAPP | 0.14% |
Iovance Biotherapeutics Inc | IOVA | 0.14% |
Stoke Therapeutics Inc | STOK | 0.14% |
Amylyx Pharmaceuticals Inc | AMLX | 0.14% |
ANI Pharmaceuticals Inc | ANI.Pharmaceuticals.Inc | 0.14% |
Sionna Therapeutics Inc | SION | 0.13% |
AbCellera Biologics Inc | ABCL | 0.13% |
Tyra Biosciences Inc | TYRA | 0.13% |
Zymeworks Inc | Zymeworks.Inc | 0.13% |
Syndax Pharmaceuticals Inc | SNDX | 0.13% |
Sarepta Therapeutics Inc | SRPT | 0.13% |
Monte Rosa Therapeutics Inc | GLUE | 0.13% |
Innoviva Inc | INVA | 0.13% |
UroGen Pharma Ltd | UroGen.Pharma.Ltd | 0.13% |
Novocure Ltd | NVCR | 0.12% |
AnaptysBio Inc | ANAB | 0.12% |
Recursion Pharmaceuticals Inc | RXRX | 0.12% |
GH Research PLC | GHRS | 0.12% |
Bicara Therapeutics Inc | BCAX | 0.12% |
Vir Biotechnology Inc | VIR | 0.12% |
Compass Pathways Plc | CMPS | 0.12% |
Septerna Inc | Septerna.Inc | 0.12% |
Fortrea Holdings Inc | FTRE | 0.12% |
Harrow Inc | HROW | 0.12% |
Absci Corp | ABSI | 0.11% |
AtaiBeckley Inc | ATAI | 0.11% |
Ardelyx Inc | ARDX | 0.11% |
ArriVent Biopharma Inc | ArriVent.Biopharma.Inc | 0.11% |
Maze Therapeutics Inc | Maze.Therapeutics.Inc | 0.11% |
Novavax Inc | NVAX | 0.11% |
Inhibrx Biosciences Inc | Inhibrx.Biosciences.Inc | 0.1% |
Zenas Biopharma Inc | ZBIO | 0.1% |
Immunocore Holdings PLC | IMCR | 0.1% |
Xeris Biopharma Holdings Inc | XERS | 0.09% |
EyePoint Inc | EYPT | 0.09% |
Savara Inc | SVRA | 0.09% |
Personalis Inc | PSNL | 0.09% |
MannKind Corp | MNKD | 0.09% |
Collegium Pharmaceutical Inc | COLL | 0.08% |
Alvotech SA | ALVO | 0.08% |
WaVe Life Sciences Ltd | WaVe.Life.Sciences.Ltd | 0.08% |
Corvus Pharmaceuticals Inc | CRVS | 0.08% |
Cullinan Therapeutics Inc | CGEM | 0.08% |
MeiraGTx Holdings plc | MGTX | 0.08% |
Xencor Inc | XNCR | 0.08% |
ARS Pharmaceuticals Inc | SPRY | 0.08% |
BioAge Labs Inc | BioAge.Labs.Inc | 0.07% |
ORIC Pharmaceuticals Inc | ORIC | 0.07% |
Olema Pharmaceuticals Inc | OLMA | 0.07% |
Kura Oncology Inc | KURA | 0.07% |
Pacira BioSciences Inc | PCRX | 0.07% |
Eton Pharmaceuticals Inc | Eton.Pharmaceuticals.Inc | 0.07% |
Replimune Group Inc | REPL | 0.07% |
Amphastar Pharmaceuticals Inc | AMPH | 0.07% |
Sana Biotechnology Inc | SANA | 0.07% |
Solid Biosciences Inc | Solid.Biosciences.Inc | 0.07% |
Janux Therapeutics Inc | JANX | 0.06% |
Theravance Biopharma Inc | Theravance.Biopharma.Inc | 0.06% |
Geron Corp | GERN | 0.06% |
Arbutus Biopharma Corp | Arbutus.Biopharma.Corp | 0.06% |
Grifols SA | GRFS | 0.06% |
Annexon Inc | ANNX | 0.06% |
Design Therapeutics Inc | DSGN | 0.06% |
Maravai LifeSciences Holdings Inc | MRVI | 0.06% |
Phathom Pharmaceuticals Inc | PHAT | 0.06% |
Mesoblast Ltd | Mesoblast.Ltd | 0.06% |
Esperion Therapeutics Inc | ESPR | 0.06% |
Vor BioPharma Inc | VOR | 0.06% |
Zevra Therapeutics Inc | ZVRA | 0.06% |
Omeros Corp | OMER | 0.06% |
Aura Biosciences Inc | AURA | 0.05% |
CytomX Therapeutics Inc | CTMX | 0.05% |
Allogene Therapeutics Inc | ALLO | 0.05% |
Candel Therapeutics Inc | CADL | 0.05% |
Rigel Pharmaceuticals Inc | Rigel.Pharmaceuticals.Inc | 0.05% |
Castle Biosciences Inc | CSTL | 0.05% |
Aclaris Therapeutics Inc | ACRS | 0.05% |
Phibro Animal Health Corp | PAHC | 0.05% |
CorMedix Inc | CRMD | 0.05% |
Ironwood Pharmaceuticals Inc | IRWD | 0.05% |
Aquestive Therapeutics Inc | AQST | 0.05% |
4D Molecular Therapeutics Inc | FDMT | 0.04% |
Zai Lab Ltd | ZLAB | 0.04% |
First Tracks Biotherapeutics Inc | TRAXV | 0.04% |
Tectonic Therapeutic Inc | TECX | 0.04% |
Altimmune Inc | ALT | 0.04% |
Prime Medicine Inc | PRME | 0.04% |
Kyverna Therapeutics Inc | Kyverna.Therapeutics.Inc | 0.04% |
Arvinas Inc | ARVN | 0.04% |
REGENXBIO Inc | RGNX | 0.04% |
Cabaletta Bio Inc | CABA | 0.04% |
Prothena Corp PLC | Prothena.Corp.PLC | 0.04% |
Neurogene Inc | NGNE | 0.03% |
C4 Therapeutics Inc | CCCC | 0.03% |
Evolus Inc | EOLS | 0.03% |
Pacific Biosciences of California Inc | PACB | 0.03% |
Lakefront Biotherapeutics NV | LKFT | 0.03% |
Silence Therapeutics PLC | SLN | 0.03% |
Editas Medicine Inc | EDIT | 0.03% |
Sagimet Biosciences Inc | Sagimet.Biosciences.Inc | 0.03% |
Contineum Therapeutics Inc | Contineum.Therapeutics.Inc | 0.03% |
Kamada Ltd | KMDA | 0.03% |
Puma Biotechnology Inc | PBYI | 0.03% |
Enanta Pharmaceuticals Inc | ENTA | 0.03% |
Lexeo Therapeutics Inc | LXEO | 0.03% |
Larimar Therapeutics Inc | LRMR | 0.03% |
Rocket Pharmaceuticals Inc | RCKT | 0.03% |
Atea Pharmaceuticals Inc | Atea.Pharmaceuticals.Inc | 0.03% |
Vanda Pharmaceuticals Inc | VNDA | 0.03% |
Upstream Bio Inc | UPB | 0.03% |
OmniAb Inc | OABI | 0.02% |
Autolus Therapeutics PLC | AUTL | 0.02% |
SIGA Technologies Inc | SIGA | 0.02% |
Lyell Immunopharma Inc | Lyell.Immunopharma.Inc | 0.02% |
Immuneering Corp | IMRX | 0.02% |
Entrada Therapeutics Inc | TRDA | 0.02% |
Alpha Teknova Inc | TKNO | 0.02% |
Invivyd Inc | ADGI | 0.02% |
Neumora Therapeutics Inc | NMRA | 0.02% |
AC Immune SA | ACIU | 0.02% |
Fulcrum Therapeutics Inc | FULC | 0.02% |
Foghorn Therapeutics Inc | FHTX | 0.02% |
Orchestra BioMed Holdings Inc | OBIO | 0.02% |
Anavex Life Sciences Corp | AVXL | 0.02% |
Coherus Oncology Inc | CHRS | 0.02% |
Voyager Therapeutics Inc | VOYG | 0.02% |
Lifecore Biomedical Inc | LNDC | 0.02% |
Keros Therapeutics Inc | KROS | 0.02% |
Codexis Inc | CDXS | 0.02% |
Arcturus Therapeutics Holdings Inc | ARCT | 0.01% |
Bicycle Therapeutics PLC | BCYC | 0.01% |
NovaBridge Biosciences | IMAB | 0.01% |
LENZ Therapeutics Inc | LENZ | 0.01% |
Caribou Biosciences Inc | CRBU | 0.01% |
Quantum-Si Inc | QSI | 0.01% |
Tenaya Therapeutics Inc | Tenaya.Therapeutics.Inc | 0.01% |
Humacyte Inc | HUMA | 0.01% |
Pyxis Oncology Inc | PYXS | 0.01% |
Jyong Biotech Ltd | MENS | 0.01% |
PepGen Inc | PepGen.Inc | 0.01% |
Aardvark Therapeutics Inc | AARD | 0.01% |
Black Diamond Therapeutics Inc | BDTX | 0.01% |
Rani Therapeutics Holdings Inc | RANI | 0.01% |
Gossamer Bio Inc | Gossamer.Bio.Inc | 0% |
Cartesian Therapeutics Inc 12/31/2050 | Cartesian.Therapeutics.Inc.12.31.2050 | 0% |
SECURITIES LENDING - BNYM | SECURITIES.LENDING...BNYM | 0% |
OmniAb Inc 11/02/2027 | OmniAb.Inc.11.02.2027 | 0% |
Third Harmonic Bio Inc | THRD | 0% |
OmniAb Inc 11/02/2027 | OmniAb.Inc.11.02.2027 | 0% |
Novo Nordisk A/S | Novo.Nordisk.A.S | 0% |
CASH & EQUIVALENTS | CASH...EQUIVALENTS | -0.33% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
Invesco Nasdaq Biotechnology ETF (IBBQ) share price today is $32.2278.
Yes, Indians can buy shares of Invesco Nasdaq Biotechnology ETF (IBBQ) on Vested. To buy IBBQ from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Invesco Nasdaq Biotechnology ETF (IBBQ) on Vested. You can start investing in Invesco Nasdaq Biotechnology ETF (IBBQ) with a minimum investment of $1.
The 52-week high price of Invesco Nasdaq Biotechnology ETF (IBBQ) is $32.06. The 52-week low price of Invesco Nasdaq Biotechnology ETF (IBBQ) is $20.89.
The stock symbol (or ticker) of Invesco Nasdaq Biotechnology ETF is IBBQ.
Yes, you can setup SIP in Invesco Nasdaq Biotechnology ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of IBBQ on the Vested app.
The expense ratio of Invesco Nasdaq Biotechnology ETF (IBBQ) is 0.19%.
Link copied